Femasys Inc (FEMY)
Fair Value18.6% Upside
Undervalued
Analyst459.9% Upside
Market Cap21.44 M
P/E—
Yield0.0%
HealthWeak
NASDAQ
Foghorn Therapeutics Inc (FHTX)
Fair Value10.1% Upside
Fair
Analyst169.9% Upside
Market Cap251.8 M
P/E—
Yield0.0%
HealthFair
NASDAQ
Fulcrum Therapeutics Inc (FULC)
Fair Value24.4% Upside
Undervalued
Analyst-4.5% Downside
Market Cap293 M
P/E—
Yield0.0%
HealthFair
NASDAQ
Gain Therapeutics Inc (GANX)
Fair Value-11.7% Downside
Fair
Analyst269.2% Upside
Market Cap85.105 M
P/E—
Yield0.0%
HealthFair
NASDAQ
GeneDx Holdings Corp (WGS)
Fair Value-30.1% Downside
Overvalued
Analyst-0.4% Downside
Market Cap2.708 B
P/E—
Yield0.0%
HealthGood
NASDAQ
GH Research PLC (GHRS)
Fair Value-19.3% Downside
Overvalued
Analyst53.9% Upside
Market Cap1.912 B
P/E—
Yield0.0%
HealthGood
NASDAQ
Featured in
High-Momentum Stocks
High-Beta Momentum
Goodrx Holdings Inc (GDRX)
Fair Value43.4% Upside
Undervalued
Analyst17.2% Upside
Market Cap1.174 B
P/E71.2x
Yield0.0%
HealthGood
NASDAQ
Featured in
High-Momentum Stocks
High-Beta Momentum
Gossamer Bio Inc (GOSS)
Fair Value36.0% Upside
Undervalued
Analyst947.7% Upside
Market Cap71.433 M
P/E—
Yield0.0%
HealthWeak
NASDAQ
Greenwich Lifesciences Inc (GLSI)
Fair Value-32.9% Downside
Overvalued
Analyst192.6% Upside
Market Cap285.9 M
P/E—
Yield0.0%
HealthWeak
NASDAQ
GRI Bio Inc (GRI)
Fair Value25.3% Upside
Undervalued
Analyst802.4% Upside
Market Cap4.482 M
P/E—
Yield0.0%
HealthFair
NASDAQ
Guardant Health Inc (GH)
Fair Value-34.6% Downside
Overvalued
Analyst10.9% Upside
Market Cap23.774 B
P/E—
Yield0.0%
HealthGood
NASDAQ
Harmony Biosciences Holdings (HRMY)
Fair Value48.7% Upside
Undervalued
Analyst14.0% Upside
Market Cap2.419 B
P/E13.5x
Yield0.0%
HealthExcellent
NASDAQ
HCW Biologics Inc (HCWB)
Fair Value19.6% Upside
Undervalued
Market Cap3.324 M
P/E—
Yield0.0%
HealthFair
NASDAQ
Health Catalyst Inc (HCAT)
Fair Value10.3% Upside
Fair
Analyst-3.4% Downside
Market Cap142.2 M
P/E—
Yield0.0%
HealthGood
NASDAQ
High Tide Inc (HITI)
Fair Value10.6% Upside
Fair
Analyst69.1% Upside
Market Cap245.9 M
P/E—
Yield0.0%
HealthGreat
NASDAQ
Humacyte Inc (HUMA)
Fair Value45.2% Upside
Undervalued
Analyst217.3% Upside
Market Cap161.9 M
P/E—
Yield0.0%
HealthWeak
NASDAQ
Hyperfine Inc (HYPR)
Fair Value29.8% Upside
Undervalued
Analyst152.6% Upside
Market Cap85.38 M
P/E—
Yield0.0%
HealthFair
NASDAQ
I Mab (NBP)
Fair Value55.5% Upside
Bargain
Analyst466.0% Upside
Market Cap184.4 M
P/E—
Yield0.0%
HealthFair
NASDAQ
Ideaya Biosciences Inc (IDYA)
Fair Value-9.9% Downside
Fair
Analyst31.9% Upside
Market Cap3.832 B
P/E—
Yield0.0%
HealthGood
NASDAQ
IM Cannabis Corp (IMCC)
Fair Value-35.3% Downside
Overvalued
Market Cap2.562 M
P/E—
Yield0.0%
HealthFair
NASDAQ
ImageneBio Inc (IMA)
Fair Value21.7% Upside
Undervalued
Analyst271.1% Upside
Market Cap55.055 M
P/E—
Yield0.0%
HealthWeak
NASDAQ
Immatics NV (IMTX)
Fair Value-1.3% Downside
Fair
Analyst98.8% Upside
Market Cap1.212 B
P/E—
Yield0.0%
HealthFair
NASDAQ
Immuneering Corp (IMRX)
Fair Value20.2% Upside
Undervalued
Analyst272.4% Upside
Market Cap298.3 M
P/E—
Yield0.0%
HealthFair
NASDAQ
Immunocore Holdings PLC (IMCR)
Fair Value10.7% Upside
Fair
Analyst92.8% Upside
Market Cap1.67 B
P/E—
Yield0.0%
HealthFair
NASDAQ
Immunome Inc (IMNM)
Fair Value2.9% Upside
Fair
Analyst39.8% Upside
Market Cap2.925 B
P/E—
Yield0.0%
HealthFair
NASDAQ
Immunovant Inc (IMVT)
Fair Value-25.8% Downside
Overvalued
Analyst31.1% Upside
Market Cap7.702 B
P/E—
Yield0.0%
HealthFair
NASDAQ
In8bio Inc (INAB)
Fair Value34.3% Upside
Undervalued
Analyst514.0% Upside
Market Cap11.239 M
P/E—
Yield0.0%
HealthFair
NASDAQ
Inhibikase Therapeutics Inc (IKT)
Fair Value-17.6% Downside
Fair
Analyst159.7% Upside
Market Cap420.6 M
P/E—
Yield0.0%
HealthFair
NASDAQ
InMed Pharmaceuticals Inc (INM)
Fair Value6.0% Upside
Fair
Market Cap9.235 M
P/E—
Yield0.0%
HealthFair
NASDAQ
InMode Ltd (INMD)
Fair Value42.5% Upside
Undervalued
Analyst11.9% Upside
Market Cap830.6 M
P/E10.7x
Yield0.0%
HealthGreat
NASDAQ
INmune Bio Inc (INMB)
Fair Value-1.4% Downside
Fair
Analyst224.1% Upside
Market Cap59.948 M
P/E—
Yield0.0%
HealthFair
NASDAQ
Innate Pharma SA (IPHA)
Fair Value-3.1% Downside
Fair
Analyst270.4% Upside
Market Cap165 M
P/E—
Yield0.0%
HealthWeak
NASDAQ
InnovAge Holding Corp (INNV)
Fair Value-19.8% Downside
Overvalued
Analyst12.6% Upside
Market Cap1.454 B
P/E—
Yield0.0%
HealthGreat
NASDAQ
Featured in
Low-Float Small-Cap Momentum Stocks
High-Growth Small-Cap Stocks
Instil Bio Inc (TIL)
Fair Value17.5% Upside
Fair
Analyst-1.8% Downside
Market Cap48.355 M
P/E—
Yield0.0%
HealthFair
NASDAQ
Intelligent Bio Solutions Inc (INBS)
Fair Value44.4% Upside
Undervalued
Analyst566.7% Upside
Market Cap5.449 M
P/E—
Yield0.0%
HealthFair
NASDAQ
Inventiva Sa (IVA)
Fair Value-34.8% Downside
Overvalued
Analyst307.5% Upside
Market Cap829.2 M
P/E—
Yield0.0%
HealthWeak
NASDAQ
Invivyd Inc (IVVD)
Fair Value21.9% Upside
Undervalued
Analyst937.3% Upside
Market Cap284.1 M
P/E—
Yield0.0%
HealthGood
NASDAQ
INVO Fertility Inc (IVF)
Fair Value21.1% Upside
Undervalued
Market Cap4.769 M
P/E—
Yield0.0%
HealthFair
NASDAQ
ISpecimen Inc (ISPC)
Fair Value26.7% Upside
Undervalued
Market Cap3.148 M
P/E—
Yield0.0%
HealthWeak
NASDAQ
Jade Biosciences Inc (JBIO)
Fair Value-10.2% Downside
Fair
Analyst199.1% Upside
Market Cap1.066 B
P/E—
Yield0.0%
HealthFair
NASDAQ
Janux Therapeutics Inc (JANX)
Fair Value17.8% Upside
Fair
Analyst107.4% Upside
Market Cap1.068 B
P/E—
Yield0.0%
HealthGood
NASDAQ
Kalaris Therapeutics Inc (KLRS)
Fair Value20.3% Upside
Undervalued
Analyst477.6% Upside
Market Cap77.128 M
P/E—
Yield0.0%
HealthWeak
NASDAQ
Keros Therapeutics Inc (KROS)
Fair Value28.0% Upside
Undervalued
Analyst69.1% Upside
Market Cap232.6 M
P/E—
Yield0.0%
HealthFair
NASDAQ
Kodiak Sciences Inc (KOD)
Fair Value-21.5% Downside
Overvalued
Analyst105.9% Upside
Market Cap2.12 B
P/E—
Yield0.0%
HealthFair
NASDAQ
Korro Bio Inc (KRRO)
Fair Value17.7% Upside
Fair
Analyst95.4% Upside
Market Cap152.3 M
P/E—
Yield0.0%
HealthWeak
NASDAQ
Featured in
High-Beta Momentum
KORU Medical Systems Inc (KRMD)
Fair Value-1.9% Downside
Fair
Analyst88.8% Upside
Market Cap152.8 M
P/E—
Yield0.0%
HealthGood
NASDAQ
Kymera Therapeutics Inc (KYMR)
Fair Value-30.3% Downside
Overvalued
Analyst13.6% Upside
Market Cap10.149 B
P/E—
Yield0.0%
HealthFair
NASDAQ
Lantern Pharma Inc (LTRN)
Fair Value19.2% Upside
Undervalued
Market Cap17.386 M
P/E—
Yield0.0%
HealthWeak
NASDAQ